[{"Assets_0_Q2_USD":287364000.0,"CommonStockSharesOutstanding_0_Q2_shares":13785000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":13932000.0,"NetIncomeLoss_1_Q2_USD":9435000.0,"NetIncomeLoss_2_Q2_USD":13942000.0,"StockholdersEquity_0_Q2_USD":250946000.0,"EarningsPerShareBasic_1_Q2_USD":0.68,"EarningsPerShareBasic_2_Q2_USD":0.99,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":13916000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":14054000.0,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20190726"}]